Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020

SELL
$76.41 - $117.54 $15,816 - $24,330
-207 Closed
0 $0
Q3 2019

Nov 13, 2019

SELL
$61.52 - $91.1 $307 - $455
-5 Reduced 2.36%
207 $18,000
Q2 2019

Aug 15, 2019

BUY
$58.04 - $66.99 $986 - $1,138
17 Added 8.72%
212 $17,000
Q1 2019

Apr 26, 2019

SELL
$35.52 - $62.62 $603 - $1,064
-17 Reduced 8.02%
195 $12,000
Q2 2018

Aug 09, 2018

SELL
$72.38 - $92.5 $144 - $185
-2 Reduced 0.93%
212 $16,000
Q1 2018

May 16, 2018

SELL
$69.46 - $88.57 $20,351 - $25,951
-293 Reduced 57.79%
214 $19,000
Q4 2017

May 18, 2018

SELL
$65.94 - $93.31 $9,165 - $12,970
-139 Reduced 21.52%
507 $15,000
Q4 2017

Mar 07, 2018

BUY
$65.94 - $93.31 $42,597 - $60,278
646
646 $16,000

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $163M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Private Capital Group, LLC Portfolio

Follow Private Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Capital Group, LLC with notifications on news.